STRO
Sutro Biopharma Inc
$3.74
Earnings Summary
Revenue | $10.41Mn |
Net Profits | $-38.52Mn |
Net Profit Margins | -370% |
Highlights
Sutro Biopharma Inc’s revenue fell -62.94% since last year same period to $10.41Mn in the Q2 2023. On a quarterly growth basis, Sutro Biopharma Inc has generated -17.85% fall in its revenue since last 3-months.
Sutro Biopharma Inc’s net profit fell -48.1% since last year same period to $-38.52Mn in the Q2 2023. On a quarterly growth basis, Sutro Biopharma Inc has generated 23.03% jump in its net profits since last 3-months.
Sutro Biopharma Inc’s net profit margin fell -299.64% since last year same period to -370% in the Q2 2023. On a quarterly growth basis, Sutro Biopharma Inc has generated 6.31% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Sutro Biopharma Inc post its latest quarter earnings
EPS Estimate Current Quarter | -0.65 |
EPS Estimate Current Year | -0.65 |
Highlights
Sutro Biopharma Inc’s earning per share (EPS) estimates for the current quarter stand at -0.65 - a 0% jump from last quarter’s estimates.
Sutro Biopharma Inc’s earning per share (EPS) estimates for the current year stand at -0.65.
Key Ratios
Key ratios of the Sutro Biopharma Inc post its Q2 2023 earnings
Earning Per Share (EPS) | 0 |
Highlights
Sutro Biopharma Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q2 2023. This indicates that the Sutro Biopharma Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-05-15 | -0.65 | 0 | 100% |
2023-08-10 | -0.65 | 0 | 100% |
₹0 US Stocks a/c Opening Fee